A prophylactic vaccine for breast cancer? Why not?

Breast Cancer Research

Volumn 12, Issue 6, 2010, Pages

  Tuohy, Vincent K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; CANCER VACCINE; MILK PROTEIN; LACTALBUMIN; CONTRACEPTIVE AGENT;

BREAST CANCER; BREAST TUMOR; CANCER GROWTH; ESTRUS CYCLE; GESTATION PERIOD; GROWTH INHIBITION; HUMAN; IMMUNIZATION; LACTATION; LETTER; METASTASIS; NONHUMAN; OVERALL SURVIVAL; PROPHYLAXIS; PROTEIN EXPRESSION; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOLOGY; METABOLISM; MOUSE; NOTE; AGING; CANCER IMMUNIZATION; CANCER RISK; CANCER SURVIVAL; IMMUNE RESPONSE; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN FUNCTION; PROTEIN TARGETING; SURVIVAL RATE; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CANCER VACCINES; FEMALE; HUMANS; LACTALBUMIN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C;

EID: 78649788544     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2775     Document Type: Letter

References (16)

1. Watson CJ, Gusterson BA. A prophylactic vaccine for breast cancer?. Breast Cancer Res 2010, 12:310-311. 10.1186/bcr2628, 20828424.
2. Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 2010, 16:799-803. 10.1038/nm.2161, 20512124.
3. Robinson GW, McKnight RA, Smith GH, Hennighausen L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 1995, 121:2079-2090.
4. Kleinberg DL, Todd J. α-Lactalbumin in human and subhuman primate normal mammary tissue and in human breast cancer as a marker for prolactin activity. Cancer Res 1978, 38:4318-4322.
5. Walker RA. The demonstration of alpha lactalbumin in human breast carcinomas. J Pathol 1979, 129:37-42. 10.1002/path.1711290107, 230330.
6. Martin RH, Glass MR, Chapman C, Wilson GD, Woods KL. Suppression by bromocriptine of the serum lactalbumin peak associated with human lactogenesis. Clin Endocrinol (Oxf) 1981, 14:363-366. 10.1111/j.1365-2265.1981.tb00621.x, 7261418.
7. Clayton F, Sibley RK, Ordonez NG, Hanssen G. Argyrophilic breast carcinomas: evidence of lactational differentiation. Am J Surg Pathol 1982, 6:323-333. 10.1097/00000478-198206000-00005, 6180651.
8. Lee AK, DeLellis RA, Rosen PP, Herbert-Stanton T, Tallberg K, Garcia C, Wolfe HJ. Alpha-lactalbumin as an immunohistochemical marker for metastatic breast carcinomas. Am J Surg Pathol 1984, 8:93-100. 10.1097/00000478-198402000-00002, 6322603.
9. Lee AK, Rosen PP, DeLellis RA, Saigo PE, Gangi MD, Groshen S, Bagin R, Wolfe HJ. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am J Clin Pathol 1985, 84:687-696.
10. Cohen C, Sharkey FE, Shulman G, Uthman EO, Budgeon LR. Tumor associated antigens in breast carcinomas. Prognostic significance. Cancer 1987, 60:1294-1298. 10.1002/1097-0142(19870915)60:6<1294::AID-CNCR2820600622>3.0.CO;2-2, 3040212.
11. Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G, Spona J. Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract 1988, 183:277-283.
12. Li X, Zhang J, Gao H, Vieth E, Bae KH, Zhang YP, Lee SJ, Raikwar S, Gardner TA, Hutchins GD, VanderPutten D, Kao C, Jeng MH. Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by alpha-lactalbumin promoter. Mol Cancer Ther 2005, 4:1850-1859. 10.1158/1535-7163.MCT-05-0167, 16373700.
13. Anderson LM, Swaminathan S, Zackon I, Tajuddin AK, Thimmapaya B, Weitzman SA. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer. Gene Ther 1999, 6:854-864. 10.1038/sj.gt.3300909, 10505111.
14. Anderson LM, Krotz S, Weitzman SA, Thimmapaya B. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Cancer Gene Ther 2000, 7:845-852. 10.1038/sj.cgt.7700191, 10880014.
15. Thomas DL, Fraser NW. HSV-1 Therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer. Mol Ther 2003, 8:543-551. 10.1016/S1525-0016(03)00236-3, 14529826.
16. Bailey AJ, Sloane JP, Trickey BS, Ormerod MG. An immunocytochemical study of α-lactalbumin in human breast tissue. J Pathol 1982, 137:13-23. 10.1002/path.1711370103, 7045307.